The CRC Blueprint

My scientific approach to my own cancer – shared with you.

United States

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

Phase 3 · randomised · 600 people · 166 sites in 12 countries · Recruiting now

August 7, 2026
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Phase 3 · randomised · 990 people · 281 sites in 26 countries · Recruiting now

August 7, 2026
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

Phase 3 · randomised · 1,912 people · 1,066 sites in 3 countries · Recruiting now

August 7, 2026
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer

Phase 3 · randomised · 477 people · 223 sites in 29 countries · Recruiting now

August 7, 2026